Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Goddard

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Depression and Anxiety|December 5, 2009
Current perspectives of the roles of the central norepinephrine system in anxiety and depressionAndrew W Goddard, Susan G Ball, James Martinez, et al.
Psychiatric Services (Washington, D.C.)|May 17, 2016
Trends in Use and Cost of Second-Generation Antipsychotics Among Children and Teens in Indiana Medicaid, 2004-2012Andrew W Goddard, Katherine Schwartz, Kristin Hendrix, et al.
Psychiatric Services (Washington, D.C.)|September 3, 2011
Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorderKaren L Rascati, Kristin M Richards, Carol A Ott, et al.
Nature Medicine|December 29, 2009
A key role for orexin in panic anxietyPhilip L Johnson, William Truitt, Stephanie D Fitz, et al.
The Journal of Clinical Psychiatry|July 12, 2013
Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorderEric A Storch, Andrew W Goddard, Jon E Grant, et al.
Depression and Anxiety|May 11, 2010
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorderVladimir Coric, Howard H Feldman, Dan A Oren, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Depression and Anxiety|December 5, 2009
Current perspectives of the roles of the central norepinephrine system in anxiety and depressionAndrew W Goddard, Susan G Ball, James Martinez, et al.
Psychiatric Services (Washington, D.C.)|May 17, 2016
Trends in Use and Cost of Second-Generation Antipsychotics Among Children and Teens in Indiana Medicaid, 2004-2012Andrew W Goddard, Katherine Schwartz, Kristin Hendrix, et al.
Psychiatric Services (Washington, D.C.)|September 3, 2011
Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorderKaren L Rascati, Kristin M Richards, Carol A Ott, et al.
Nature Medicine|December 29, 2009
A key role for orexin in panic anxietyPhilip L Johnson, William Truitt, Stephanie D Fitz, et al.
The Journal of Clinical Psychiatry|July 12, 2013
Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorderEric A Storch, Andrew W Goddard, Jon E Grant, et al.
Depression and Anxiety|May 11, 2010
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorderVladimir Coric, Howard H Feldman, Dan A Oren, et al.
Pageof 2